Q1 Earnings Estimate for VRDN Issued By B. Riley
Viridian Therapeutics, Inc. (NASDAQ:VRDN – Free Report) – Investment analysts at B. Riley issued their Q1 2025 earnings per share estimates for Viridian Therapeutics in a research report issued to clients and investors on Monday, March 3rd. B. Riley analyst K. Patel forecasts that the company will post earnings of ($1.09) per share for the ...
Publicado el: 2025-03-07 06:48:56
Autor: MarketBeat News, Fuente: etfdailynews
Compartir: 
